2 completed. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
Follow codrituzumab: new trials by email Literature Review of codrituzumab trials Research Report on codrituzumab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of GC33 and Sorafenib in Combination in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) GC33(RO5137382), Sorafenib - Hepatocellular Carcinoma | Phase 1 | Completed | Chugai Pharmaceutical | 42 | 2009-09-01 | 2014-10-03 |
| A Phase I Study of GC33 in Advanced or Metastatic Liver Cancer (Hepatocellular Carcinoma) GC33 - Advanced or Metastatic HCC | Phase 1 | Completed | Chugai Pharmaceutical | 27 | 2008-09-01 | 2012-10-17 |
United States (2) · Taiwan (1)
Toshihiko Ohtomo (1)